Actions of epoxygenase metabolites on the preglomerular vasculature

John D. Imig, L. G. Navar, Richard J. Roman, K. Kishta Reddy, J R Falck

Research output: Contribution to journalArticle

163 Citations (Scopus)

Abstract

Epoxygenase metabolites of arachidonic acid are produced by the kidney and have been implicated in the control of renal blood flow. This study examined the preglomerular actions of various epoxyeicosatrienoic acids (EET). By use of the in vitro blood-perfused juxtamedullary nephron preparation, interlobular and afferent arteriolar diameter responses to 5,6- EET, 8,9-EET, 11,12-EET, and 14,15-EET were determined. Diameters of interlobular and afferent arterioles preconstricted with 0.5 μM norepinephrine averaged 24 ± 1 μm (N = 27) and 17 ± 1 μm (N = 32), respectively, at a renal perfusion pressure of 100 mm Hg. Superfusion with 0.01 to 100 nM 11,12-EET caused graded increases in diameters of the interlobular and afferent arterioles. At a dose of 100 nM, 11,12-EET increased the diameters of the interlobular and afferent arterioles by 18 ± 2% (N = 10) and 20 ± 3% (N = 9), respectively. The vasodilatory response to 11,12-EET was stereoselective because 11,12(R,S)-EET but not 11,12(S,R)-EET increased the diameters of the interlobular and afferent arterioles. 14,15- EET had a much smaller effect and increased the diameters of the these vessels by 10%; 8,9-EET did not significantly affect vascular diameters. In contrast, 5,6-EET constricted the interlobular and afferent arterioles by 16 ± 3% (N = 6) and 21 ± 3% (N = 7), respectively. The corresponding diols, 5,6-DIHETE and 11,12-DIHETE, had no effect on diameters of the interlobular and afferent arterioles at concentrations up to 1 μM. The vasodilatory response to 11,12-EET was not affected by removal of the endothelium or by inhibition of cyclooxygenase with indomethacin. In contrast, the vasoconstrictor response to 5,6-EET was abolished by both removal of the endothelium or cyclooxygenase inhibition. The thromboxane/enderoperoxide receptor inhibitor, SQ 29,548, resulted in a 60% attenuation of the afferent arteriolar vasoconstriction to 5,6-EET. These results indicate that the preglomerular vasoconstriction to 5,6-EET is cyclooxygenase dependent and requires an intact endothelium, whereas the vasodilation to 11,12-EET is stereoselective and is the result of direct action of the epoxide on the preglomerular vascular smooth muscle.

Original languageEnglish (US)
Pages (from-to)2364-2370
Number of pages7
JournalJournal of the American Society of Nephrology
Volume7
Issue number11
StatePublished - Nov 1996

Fingerprint

Arterioles
Prostaglandin-Endoperoxide Synthases
Endothelium
Vasoconstriction
Thromboxane Receptors
Kidney
Acids
Renal Circulation
Epoxy Compounds
Nephrons
Vasoconstrictor Agents
11,12-epoxy-5,8,14-eicosatrienoic acid
Vascular Smooth Muscle
Vasodilation
Indomethacin
Blood Vessels
Norepinephrine
Perfusion
5,6-epoxy-8,11,14-eicosatrienoic acid
Pressure

Keywords

  • Afferent arteriole
  • Cyclooxygenase
  • Endothelium
  • Epoxyelcosatrienoic acid
  • Kidney

ASJC Scopus subject areas

  • Nephrology

Cite this

Actions of epoxygenase metabolites on the preglomerular vasculature. / Imig, John D.; Navar, L. G.; Roman, Richard J.; Reddy, K. Kishta; Falck, J R.

In: Journal of the American Society of Nephrology, Vol. 7, No. 11, 11.1996, p. 2364-2370.

Research output: Contribution to journalArticle

Imig, JD, Navar, LG, Roman, RJ, Reddy, KK & Falck, JR 1996, 'Actions of epoxygenase metabolites on the preglomerular vasculature', Journal of the American Society of Nephrology, vol. 7, no. 11, pp. 2364-2370.
Imig, John D. ; Navar, L. G. ; Roman, Richard J. ; Reddy, K. Kishta ; Falck, J R. / Actions of epoxygenase metabolites on the preglomerular vasculature. In: Journal of the American Society of Nephrology. 1996 ; Vol. 7, No. 11. pp. 2364-2370.
@article{92ef1dd603f54eabbf2c2b2d2ad541b7,
title = "Actions of epoxygenase metabolites on the preglomerular vasculature",
abstract = "Epoxygenase metabolites of arachidonic acid are produced by the kidney and have been implicated in the control of renal blood flow. This study examined the preglomerular actions of various epoxyeicosatrienoic acids (EET). By use of the in vitro blood-perfused juxtamedullary nephron preparation, interlobular and afferent arteriolar diameter responses to 5,6- EET, 8,9-EET, 11,12-EET, and 14,15-EET were determined. Diameters of interlobular and afferent arterioles preconstricted with 0.5 μM norepinephrine averaged 24 ± 1 μm (N = 27) and 17 ± 1 μm (N = 32), respectively, at a renal perfusion pressure of 100 mm Hg. Superfusion with 0.01 to 100 nM 11,12-EET caused graded increases in diameters of the interlobular and afferent arterioles. At a dose of 100 nM, 11,12-EET increased the diameters of the interlobular and afferent arterioles by 18 ± 2{\%} (N = 10) and 20 ± 3{\%} (N = 9), respectively. The vasodilatory response to 11,12-EET was stereoselective because 11,12(R,S)-EET but not 11,12(S,R)-EET increased the diameters of the interlobular and afferent arterioles. 14,15- EET had a much smaller effect and increased the diameters of the these vessels by 10{\%}; 8,9-EET did not significantly affect vascular diameters. In contrast, 5,6-EET constricted the interlobular and afferent arterioles by 16 ± 3{\%} (N = 6) and 21 ± 3{\%} (N = 7), respectively. The corresponding diols, 5,6-DIHETE and 11,12-DIHETE, had no effect on diameters of the interlobular and afferent arterioles at concentrations up to 1 μM. The vasodilatory response to 11,12-EET was not affected by removal of the endothelium or by inhibition of cyclooxygenase with indomethacin. In contrast, the vasoconstrictor response to 5,6-EET was abolished by both removal of the endothelium or cyclooxygenase inhibition. The thromboxane/enderoperoxide receptor inhibitor, SQ 29,548, resulted in a 60{\%} attenuation of the afferent arteriolar vasoconstriction to 5,6-EET. These results indicate that the preglomerular vasoconstriction to 5,6-EET is cyclooxygenase dependent and requires an intact endothelium, whereas the vasodilation to 11,12-EET is stereoselective and is the result of direct action of the epoxide on the preglomerular vascular smooth muscle.",
keywords = "Afferent arteriole, Cyclooxygenase, Endothelium, Epoxyelcosatrienoic acid, Kidney",
author = "Imig, {John D.} and Navar, {L. G.} and Roman, {Richard J.} and Reddy, {K. Kishta} and Falck, {J R}",
year = "1996",
month = "11",
language = "English (US)",
volume = "7",
pages = "2364--2370",
journal = "Journal of the American Society of Nephrology",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "11",

}

TY - JOUR

T1 - Actions of epoxygenase metabolites on the preglomerular vasculature

AU - Imig, John D.

AU - Navar, L. G.

AU - Roman, Richard J.

AU - Reddy, K. Kishta

AU - Falck, J R

PY - 1996/11

Y1 - 1996/11

N2 - Epoxygenase metabolites of arachidonic acid are produced by the kidney and have been implicated in the control of renal blood flow. This study examined the preglomerular actions of various epoxyeicosatrienoic acids (EET). By use of the in vitro blood-perfused juxtamedullary nephron preparation, interlobular and afferent arteriolar diameter responses to 5,6- EET, 8,9-EET, 11,12-EET, and 14,15-EET were determined. Diameters of interlobular and afferent arterioles preconstricted with 0.5 μM norepinephrine averaged 24 ± 1 μm (N = 27) and 17 ± 1 μm (N = 32), respectively, at a renal perfusion pressure of 100 mm Hg. Superfusion with 0.01 to 100 nM 11,12-EET caused graded increases in diameters of the interlobular and afferent arterioles. At a dose of 100 nM, 11,12-EET increased the diameters of the interlobular and afferent arterioles by 18 ± 2% (N = 10) and 20 ± 3% (N = 9), respectively. The vasodilatory response to 11,12-EET was stereoselective because 11,12(R,S)-EET but not 11,12(S,R)-EET increased the diameters of the interlobular and afferent arterioles. 14,15- EET had a much smaller effect and increased the diameters of the these vessels by 10%; 8,9-EET did not significantly affect vascular diameters. In contrast, 5,6-EET constricted the interlobular and afferent arterioles by 16 ± 3% (N = 6) and 21 ± 3% (N = 7), respectively. The corresponding diols, 5,6-DIHETE and 11,12-DIHETE, had no effect on diameters of the interlobular and afferent arterioles at concentrations up to 1 μM. The vasodilatory response to 11,12-EET was not affected by removal of the endothelium or by inhibition of cyclooxygenase with indomethacin. In contrast, the vasoconstrictor response to 5,6-EET was abolished by both removal of the endothelium or cyclooxygenase inhibition. The thromboxane/enderoperoxide receptor inhibitor, SQ 29,548, resulted in a 60% attenuation of the afferent arteriolar vasoconstriction to 5,6-EET. These results indicate that the preglomerular vasoconstriction to 5,6-EET is cyclooxygenase dependent and requires an intact endothelium, whereas the vasodilation to 11,12-EET is stereoselective and is the result of direct action of the epoxide on the preglomerular vascular smooth muscle.

AB - Epoxygenase metabolites of arachidonic acid are produced by the kidney and have been implicated in the control of renal blood flow. This study examined the preglomerular actions of various epoxyeicosatrienoic acids (EET). By use of the in vitro blood-perfused juxtamedullary nephron preparation, interlobular and afferent arteriolar diameter responses to 5,6- EET, 8,9-EET, 11,12-EET, and 14,15-EET were determined. Diameters of interlobular and afferent arterioles preconstricted with 0.5 μM norepinephrine averaged 24 ± 1 μm (N = 27) and 17 ± 1 μm (N = 32), respectively, at a renal perfusion pressure of 100 mm Hg. Superfusion with 0.01 to 100 nM 11,12-EET caused graded increases in diameters of the interlobular and afferent arterioles. At a dose of 100 nM, 11,12-EET increased the diameters of the interlobular and afferent arterioles by 18 ± 2% (N = 10) and 20 ± 3% (N = 9), respectively. The vasodilatory response to 11,12-EET was stereoselective because 11,12(R,S)-EET but not 11,12(S,R)-EET increased the diameters of the interlobular and afferent arterioles. 14,15- EET had a much smaller effect and increased the diameters of the these vessels by 10%; 8,9-EET did not significantly affect vascular diameters. In contrast, 5,6-EET constricted the interlobular and afferent arterioles by 16 ± 3% (N = 6) and 21 ± 3% (N = 7), respectively. The corresponding diols, 5,6-DIHETE and 11,12-DIHETE, had no effect on diameters of the interlobular and afferent arterioles at concentrations up to 1 μM. The vasodilatory response to 11,12-EET was not affected by removal of the endothelium or by inhibition of cyclooxygenase with indomethacin. In contrast, the vasoconstrictor response to 5,6-EET was abolished by both removal of the endothelium or cyclooxygenase inhibition. The thromboxane/enderoperoxide receptor inhibitor, SQ 29,548, resulted in a 60% attenuation of the afferent arteriolar vasoconstriction to 5,6-EET. These results indicate that the preglomerular vasoconstriction to 5,6-EET is cyclooxygenase dependent and requires an intact endothelium, whereas the vasodilation to 11,12-EET is stereoselective and is the result of direct action of the epoxide on the preglomerular vascular smooth muscle.

KW - Afferent arteriole

KW - Cyclooxygenase

KW - Endothelium

KW - Epoxyelcosatrienoic acid

KW - Kidney

UR - http://www.scopus.com/inward/record.url?scp=0030358016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030358016&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 2364

EP - 2370

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

SN - 1046-6673

IS - 11

ER -